{
     "PMID": "19560101",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090922",
     "LR": "20161125",
     "IS": "1552-5279 (Electronic) 1552-5260 (Linking)",
     "VI": "5",
     "IP": "4",
     "DP": "2009 Jul",
     "TI": "Markers of Alzheimer's disease in a population attending a memory clinic.",
     "PG": "307-17",
     "LID": "10.1016/j.jalz.2009.04.1235 [doi]",
     "AB": "BACKGROUND: New marker-based criteria for the diagnosis of Alzheimer's disease (AD) were recently proposed. We describe their operational translation in 144 consecutive patients referred to our Memory Clinic. METHODS: Visual ratings of hippocampal atrophy and of cortical glucose hypometabolism in magnetic resonance imaging and positron emission tomography, and concentrations of total tau and Abeta1-42 in cerebrospinal fluid were assessed in 12 patients with subjective memory complaints (SMCs) (Mini-Mental State Examination [MMSE] score, 28.0 +/- 1.1 [mean +/- SD]), 37 with mild cognitive impairment (MCI) (MMSE, 25.1 +/- 3.6), 55 with AD (MMSE, 21.1 +/- 3.5), and 40 with non-AD dementia (MMSE, 21.6 +/- 5.5). RESULTS: The sensitivity for AD of each individual biomarker was higher (65% to 87%) than for MCI (18% to 50%). Each biomarker's specificity for SMC and non-AD dementias was good to moderate (83% and 53%). Positivity for at least one marker increased the probability 38 times of belonging to the AD group (P < 0.0001). CONCLUSION: The new diagnostic criteria can be operationalized in clinical routines, but longitudinal studies of MCI patients will need to assess the criteria's prognostic value.",
     "FAU": [
          "Frisoni, Giovanni B",
          "Prestia, Annapaola",
          "Zanetti, Orazio",
          "Galluzzi, Samantha",
          "Romano, Melissa",
          "Cotelli, Maria",
          "Gennarelli, Massimo",
          "Binetti, Giuliano",
          "Bocchio, Luisella",
          "Paghera, Barbara",
          "Amicucci, Giovanni",
          "Bonetti, Matteo",
          "Benussi, Luisa",
          "Ghidoni, Roberta",
          "Geroldi, Cristina"
     ],
     "AU": [
          "Frisoni GB",
          "Prestia A",
          "Zanetti O",
          "Galluzzi S",
          "Romano M",
          "Cotelli M",
          "Gennarelli M",
          "Binetti G",
          "Bocchio L",
          "Paghera B",
          "Amicucci G",
          "Bonetti M",
          "Benussi L",
          "Ghidoni R",
          "Geroldi C"
     ],
     "AD": "Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy. gfrisoni@fatebenefratelli.it",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Alzheimers Dement",
     "JT": "Alzheimer's & dementia : the journal of the Alzheimer's Association",
     "JID": "101231978",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Biomarkers)",
          "0 (Peptide Fragments)",
          "0 (amyloid beta-protein (1-42))",
          "0 (tau Proteins)",
          "IY9XDZ35W2 (Glucose)"
     ],
     "SB": "IM",
     "MH": [
          "Aged",
          "Aged, 80 and over",
          "Alzheimer Disease/cerebrospinal fluid/diagnostic imaging/*pathology",
          "Amyloid beta-Peptides/analysis/*cerebrospinal fluid",
          "Atrophy/cerebrospinal fluid/diagnostic imaging/pathology",
          "Biomarkers/analysis/cerebrospinal fluid",
          "Cerebral Cortex/diagnostic imaging/metabolism/physiopathology",
          "Cognition Disorders/cerebrospinal fluid/diagnostic imaging/pathology",
          "Cohort Studies",
          "Female",
          "Glucose/*metabolism",
          "Hippocampus/diagnostic imaging/metabolism/*pathology",
          "Humans",
          "Magnetic Resonance Imaging",
          "Male",
          "Memory Disorders/cerebrospinal fluid/diagnostic imaging/*pathology",
          "Middle Aged",
          "Neuropsychological Tests",
          "Peptide Fragments/analysis/*cerebrospinal fluid",
          "Positron-Emission Tomography",
          "Predictive Value of Tests",
          "Sensitivity and Specificity",
          "tau Proteins/analysis/*cerebrospinal fluid"
     ],
     "EDAT": "2009/06/30 09:00",
     "MHDA": "2009/09/23 06:00",
     "CRDT": [
          "2009/06/30 09:00"
     ],
     "PHST": [
          "2008/11/24 00:00 [received]",
          "2009/03/27 00:00 [revised]",
          "2009/04/20 00:00 [accepted]",
          "2009/06/30 09:00 [entrez]",
          "2009/06/30 09:00 [pubmed]",
          "2009/09/23 06:00 [medline]"
     ],
     "AID": [
          "S1552-5260(09)00102-2 [pii]",
          "10.1016/j.jalz.2009.04.1235 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Alzheimers Dement. 2009 Jul;5(4):307-17. doi: 10.1016/j.jalz.2009.04.1235.",
     "term": "hippocampus"
}